Clinical Trials of interest to cytokine & interferon researchers. Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT ClinicalTrials.gov ID NCT06130579 Sponsor: Peking University People’s Hospital Information provided by Xiao-Jun Huang, Peking University People’s Hospital (Responsible Party) Last Update Posted 2024-03-21 MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in [READ MORE]
My research interests include understanding the opposing challenges faced by the immune system in response to micro- vs. macro- parasites and is studying the relationship between type 2 cytokines and IL-17 … particularly the evolutionary relationship between type 2 immunity, parasite control and tissue repair and is currently investigating how [READ MORE]
Congratulations to the newly-elected officers of the ICIS! Several are returning members, while others are joining the board for the first time. It is great to see so many people willing to give generously of their time and “sweat equity” (to adopt a turn of phrase from former ICIS President [READ MORE]
ICIS Council member, Carla Rothlin, Ph.D., recently interviewed Yale University’s Day of Immunology co-founders Dr. Lindsey Hughes, Sarah Ohashi and Sasha Tabachnikova. The following is a lightly edited summary of their conversation. What is Day of Immunology? Day of Immunology is an annual outreach event designed to introduce high school [READ MORE]
My research focuses on the immune responses to emerging viral infections and vaccines in humans, with emphasis on older adults. The best advice I received was by the incredibly talented mentors I had and, in brief, it is to stay curious, celebrate wins no matter if they are big or [READ MORE]
Howard Young has long been a proponent of employing treats to help maintain positive interactions among personnel in the laboratory. A Chocolate Peanut Butter Cake is an indulgent dessert that will promote the same level of harmony in the lab that is achieved in the rich chocolate and creamy peanut [READ MORE]
Lightening Talks and Networking Opportunities Cytokines 2024 and KAI 2024 is your unique opportunity to learn from global thought leaders in Cytokine and Interferon research and gain the insights, techniques, and experiences you need to build a vital network to amplify your impact. Event highlights include opportunities to: Meet senior [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers Pegylated Interferon Lambda for Treatment of COVID-19 Infection ClinicalTrials.gov ID NCT04534673 Sponsor Soroka University Medical Center Information provided by Ohad Etzion, Soroka University Medical Center (Responsible Party) Last Update Posted 2023-05-06 Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score [READ MORE]
My research focuses on immune metabolism and cancer microenvironment, and as a surgeon-scientist in training, I am deeply interested in improving the outcomes of liver cancer patients. Regarding my hobbies, I really like swimming. Lastly, the best advice I’ve received is that life is an experience. This simple yet profound [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma (ATPIC) ClinicalTrials.gov ID NCT05867004 Sponsor Institut Claudius Regaud Information provided by Institut Claudius Regaud (Responsible Party) Last Update Posted 2023 Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
